retatrutide peptide triple hormone receptor agonist glp-1 gip glucagon phase 2 nejm 2023 Medscape retatrutide triple hormone receptor agonist

It helps with weight loss and supports metabolic health, making it ideal for those with a BMI of 30 or higher, or a BMI of 27 with obesity-related conditions like high blood pressure, high cholesterol, prediabetes, or type 2 diabetes

Real-world data on effectiveness and safety may differ from findings in controlled studies, highlighting the need for additional larger-scale studies and real-world data to guide clinical decision-making

Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, and your dose may increase over time without a price change, making multi-month budgeting predictable

Key Details: Eli Lilly launched its Employer Connect program in March 2026 with more than 15 independent partners, each offering a different model for employers to cover Zepbound

PMID 29439603

doi: 10.1038/nrmicro1789 10 DummlerA.LawrenceA